日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Association between CFTR modulators and changes in iron deficiency markers in cystic fibrosis

囊性纤维化中CFTR调节因子与铁缺乏标志物变化之间的关联

期刊:Journal of Cystic Fibrosis
影响因子:6
doi:10.1016/j.jcf.2024.03.002
Jia, Shijing; Wang, Yizhuo; Ross, Melissa H; Zuckerman, Jonathan B; Murray, Susan; Han, MeiLan K; Cahalan, Shannon E; Lenhan, Blair E; Best, Ryan N; Taylor-Cousar, Jennifer L; Simon, Richard H; Fitzgerald, Linda J; Troost, Jonathan P; Sood, Suman L; Gifford, Alex H
CFTR
发表日期：2024
文献求助 收藏

The effect of discontinuing hypertonic saline or dornase alfa on mucociliary clearance in elexacaftor/tezacaftor/ivacaftor treated people with cystic fibrosis: The SIMPLIFY-MCC Study

停用高渗盐水或重组人脱氧核糖核酸酶对接受依来卡托/替扎卡托/伊伐卡托治疗的囊性纤维化患者黏液纤毛清除功能的影响：SIMPLIFY-MCC 研究

期刊:Journal of Cystic Fibrosis
影响因子:6
doi:10.1016/j.jcf.2024.02.003
Donaldson, Scott H; Corcoran, Timothy E; Pilewski, Joseph M; Laube, Beth L; Mogayzel, Peter; Ceppe, Agathe; Wu, Jihong; Zeman, Kirby; Rowe, Steven M; Nichols, David P; Gifford, Alex H; Bennett, William D; Mayer-Hamblett, Nicole
MPL
LIF
发表日期：2024
文献求助 收藏

Impact of Discontinuing Both Hypertonic Saline and Dornase Alfa after Elexacaftor-Tezacaftor-Ivacaftor in Cystic Fibrosis

囊性纤维化患者在接受 Elexacaftor-Tezacaftor-Ivacaftor 治疗后停用高渗盐水和 Dornase Alfa 的影响

期刊:Annals of the American Thoracic Society
影响因子:5.4
doi:10.1513/AnnalsATS.202404-366OC
Mayer-Hamblett, Nicole; Gifford, Alex H; Kloster, Margaret; Russell, Renee; Braun, Andrew T; Gibson, Ronald L; Hoppe, Jordana E; Jain, Raksha; Linnemann, Rachel W; Liou, Theodore G; Lysinger, Jerimiah; Milla, Carlos; Riekert, Kristin A; Sawicki, Gregory S; Young, Julia; Nichols, David
发表日期：2024
文献求助 收藏

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

在接受调节剂治疗的囊性纤维化患者中，停用高渗盐水或重组人脱氧核糖核酸酶（dornase alfa）与继续使用高渗盐水或dornase alfa的疗效比较（SIMPLIFY）：两项平行、多中心、开放标签、随机、对照、非劣效性试验的结果

期刊:Lancet Respiratory Medicine
影响因子:32.8
doi:10.1016/S2213-2600(22)00434-9
Mayer-Hamblett, Nicole; Ratjen, Felix; Russell, Renee; Donaldson, Scott H; Riekert, Kristin A; Sawicki, Gregory S; Odem-Davis, Katherine; Young, Julia K; Rosenbluth, Daniel; Taylor-Cousar, Jennifer L; Goss, Christopher H; Retsch-Bogart, George; Clancy, John Paul; Genatossio, Alan; O'Sullivan, Brian P; Berlinski, Ariel; Millard, Susan L; Omlor, Gregory; Wyatt, Colby A; Moffett, Kathryn; Nichols, David P; Gifford, Alex H
MPL
LIF
发表日期：2023
文献求助 收藏

Complications and Practice Variation in the Use of Peripherally Inserted Central Venous Catheters in People With Cystic Fibrosis: The Prospective Study of Peripherally Inserted Venous Catheters in People With Cystic Fibrosis Study

囊性纤维化患者外周置入中心静脉导管使用中的并发症和实践差异：囊性纤维化患者外周置入静脉导管前瞻性研究

期刊:Chest
影响因子:8.6
doi:10.1016/j.chest.2023.03.043
Gifford, Alex H; Hinton, Alexandra C; Jia, Shijing; Nasr, Samya Z; Mermis, Joel D; Lahiri, Thomas; Zemanick, Edith T; Teneback, Charlotte C; Flume, Patrick A; DiMango, Emily A; Sadeghi, Hossein; Polineni, Deepika; Dezube, Rebecca H; West, Natalie E; Dasenbrook, Elliott C; Lucas, F Lee; Zuckerman, Jonathan B
发表日期：2023
文献求助 收藏

Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs

评估新冠疫情期间美国囊性纤维化项目中远程医疗的障碍和促进因素

期刊:Journal of Cystic Fibrosis
影响因子:6
doi:10.1016/j.jcf.2021.08.034
Gifford, Alex H; Ong, Thida; Dowd, Christopher; Van Citters, Aricca D; Scalia, Peter; Sabadosa, Kathryn A; Sawicki, Gregory S
微生物学
新冠
发表日期：2021
文献求助 收藏

Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study Design

评估囊性纤维化患者在接受调节剂药物治疗后停止慢性治疗的影响：SIMPLIFY 临床试验研究设计

期刊:Annals of the American Thoracic Society
影响因子:5.4
doi:10.1513/AnnalsATS.202010-1336SD
Mayer-Hamblett, Nicole; Nichols, David P; Odem-Davis, Katherine; Riekert, Kristin A; Sawicki, Greg S; Donaldson, Scott H; Ratjen, Felix; Konstan, Michael W; Simon, Noah; Rosenbluth, Daniel B; Retsch-Bogart, George; Clancy, John P; VanDalfsen, Jill M; Buckingham, Rachael; Gifford, Alex H
MPL
LIF
发表日期：2021
文献求助 收藏

Calprotectin-Mediated Zinc Chelation Inhibits Pseudomonas aeruginosa Protease Activity in Cystic Fibrosis Sputum

钙卫蛋白介导的锌螯合作用抑制囊性纤维化痰液中铜绿假单胞菌蛋白酶的活性

期刊:Journal of Bacteriology
影响因子:3
doi:10.1128/JB.00100-21
Vermilyea, Danielle M; Crocker, Alex W; Gifford, Alex H; Hogan, Deborah A
发表日期：2021
文献求助 收藏

Use of proton pump inhibitors is associated with lower hemoglobin levels in people with cystic fibrosis

使用质子泵抑制剂与囊性纤维化患者的血红蛋白水平降低有关。

期刊:Pediatric Pulmonology
影响因子:2.3
doi:10.1002/ppul.25431
Gifford, Alex H; Sanville, Julie L; Sathe, Meghana; Heltshe, Sonya L; Goss, Christopher H
发表日期：2021
文献求助 收藏

Answering the call to address cystic fibrosis treatment burden in the era of highly effective CFTR modulator therapy

在高效CFTR调节剂疗法时代，响应解决囊性纤维化治疗负担的呼吁

期刊:Journal of Cystic Fibrosis
影响因子:6
doi:10.1016/j.jcf.2019.11.007
Gifford, Alex H; Mayer-Hamblett, Nicole; Pearson, Kelsie; Nichols, David P
CFTR
发表日期：2020
文献求助 收藏